STIM

STIM

USD

Neuronetics Inc. Common Stock

$2.870+0.490 (20.588%)

Precio en Tiempo Real

Healthcare
Dispositivos médicos
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$2.380

Máximo

$3.090

Mínimo

$2.380

Volumen

0.12M

Fundamentos de la Empresa

Capitalización de Mercado

189.8M

Industria

Dispositivos médicos

País

United States

Estadísticas de Negociación

Volumen Promedio

1.33M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $0.52Actual $2.870Máximo $5.92

Noticias Relacionadas

GlobeNewswire

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

Delivered $37.3 million total revenue in Q3 2025, representing 11% adjusted pro forma revenue growth versus Q3 2024 Generated Greenbrook clinic revenue of $21.8 million in Q3 2025, an increase of 25% on an adjusted

Ver más
Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan
GlobeNewswire

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life

Ver más
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

MALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who

Ver más
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
GlobeNewswire

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who

Ver más
Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.